RAC 2.20% $1.78 race oncology ltd

Ann: Updated Strategy and Investor Presentation, page-244

  1. 8,545 Posts.
    lightbulb Created with Sketch. 1403
    In the historical study which you quote, the bisantrene dose was firstly 260mg/m2, increasing later to 320mg/m2.

    In the upcoming trials, the maximum dose will be much lower, say 50mg/m2, (because that's all that is required for FTO inhibition). So there may be no noticeable adverse side effects at all.

    Ethics requires that side effects be tracked.
    Last edited by IndexInvestor: 24/11/23
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.